Methyleugenol

Methyleugenol

SCHEMBL441965

C=CCc1ccc(OC)c(OC)c1.CC(=O)OC(C)c1ccccc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.62
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
CYP3A4 P08684 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
ALDH1A1 P00352 4/20 0.58
PPARA Q07869 3/20 0.58
PPARG P37231 1/20 0.58
PPARD Q03181 1/20 0.58
CCR3 P51677 1/20 0.58
KDM4E B2RXH2 3/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 1/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
ALOX5 P09917 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL441966 0.85 KMT2A (0.57) PTGS1KMT2AMEN1CYP3A4TDP1
Methyleugenol SCHEMBL28484578 0.82 PPARA (0.81) PTGS1KMT2AMEN1CYP3A4TDP1
Methyleugenol SCHEMBL28889555 0.79 MEN1 (0.67) PTGS1KMT2AMEN1CYP3A4TDP1
Methyleugenol SCHEMBL28236748 0.78 CYP3A4 (0.68) PTGS1KMT2AMEN1CYP3A4TDP1
Eugenyl Acetate SCHEMBL29802968 0.77 PTGS1 (1.00) PTGS1KMT2AMEN1CYP3A4TDP1
SCHEMBL16679994 0.77 PTGS1 (0.89) PTGS1KMT2AMEN1CYP3A4TDP1
Eugenyl Acetate SCHEMBL112232 0.77 PTGS1 (1.00) PTGS1KMT2AMEN1CYP3A4TDP1
Eugenyl Acetate SCHEMBL14764089 0.77 PTGS1 (1.00) PTGS1KMT2AMEN1CYP3A4TDP1
SCHEMBL16108564 0.77 PTGS1 (0.62) PTGS1KMT2AMEN1CYP3A4TDP1
Methyleugenol SCHEMBL1869396 0.76 ALDH1A1 (1.00) PTGS1KMT2AMEN1CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents COLABS INT'L CORP. (US) 2024-03-28 US disclosed
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents CoLabs International Corporation (US) 2023-12-12 US disclosed
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CoLabs International Corporation (US) 2023-08-15 US disclosed
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent COLABS INT'L CORP. (US) 2023-07-25 US disclosed
US-20230113098-A1 Compositions Containing a Capsule with an Agent COLABS INT'L CORP. (US) 2023-04-13 US disclosed
US-20230087601-A1 COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT AMORPHOUS GRADE POLYLACTIC ACID RESIN NATUREWORKS LLC 2023-03-23 US disclosed
EP-4106881-A1 COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT AMORPHOUS GRADE POLYLACTIC ACID RESIN NatureWorks LLC (US) 2022-12-28 EP disclosed
EP-3813786-A1 COMPOSITIONS COMPRISING SILICON DIOXIDE-BASED PARTICLES INCLUDING ONE OR MORE AGENTS Colabs International Corporation (US) 2021-05-05 EP disclosed
US-20210045980-A1 Grip Enhancing Compositions, and Methods and Uses Thereof Collidion, Inc. (US) 2021-02-18 US disclosed
US-20190290940-A1 Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent CoLabs International Corporation (US) 2019-09-26 US disclosed
EP-2568954-A2 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME Segetis, Inc. (US) 2013-03-20 EP disclosed
US-8188030-B2 Fabric softener compositions and methods of manufacture thereof SEGETIS, INC. (US) 2012-05-29 US disclosed
WO-2012037122-A2 FABRIC SOFTENER COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF SEGETIS, INC. (US) 2012-03-22 WO disclosed
US-20120065113-A1 FABRIC SOFTENER COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF SEGETIS, INC. (US) 2012-03-15 US disclosed
WO-2011143242-A2 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SEGETIS, INC. (US) 2011-11-17 WO disclosed
US-20110274643-A1 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SEGETIS, INC. (US) 2011-11-10 US disclosed
WO-1998041603-A1 FABRIC LAUNDRY TREATMENT COMPOSITION UNILEVER PLC (GB) 1998-09-24 WO disclosed
WO-1996009365-A1 CLEAR CONCENTRATED FABRIC SOFTENER ANSARI, RAHMAN, H. 1996-03-28 WO disclosed
US-5492636-A CONTAINING QUATERNARY AMMONIUM CHLORIDE OR IMIDAZOLINIUM SALT FABRIC SOFTENER, BUTYL CARBITOL, FRAGRANCE, WATER; CLEAR, FREE-FLOWING LIQUID QUEST INTERNATIONAL FRAGRANCES COMPANY (US) 1996-02-20 US disclosed
US-5425887-A Hydrocarbon based quaternary ammonium salt as fabric conditioner and capsule consists of emulsion of perfume and solution of water soluble natural or synthetic polymer and water LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1995-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230087601-A1 COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT AMORPHOUS GRADE POLYLACTIC ACID RESIN CUTA, RARA, RARG PTGS1 1757/4885KMT2A 409/4885MEN1 2466/4885
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent CUTA, LIPE, LIPA PTGS1 3580/4885KMT2A 3272/4885MEN1 299/4885
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CUTA, ACMSD, TYR PTGS1 4412/4885KMT2A 4008/4885MEN1 139/4885
US-20110274643-A1 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME FASN, ELOVL6, ALOX5 PTGS1 876/4885KMT2A 284/4885MEN1 4125/4885
US-20190290940-A1 Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent CUTA, ACMSD, TYR PTGS1 4412/4885KMT2A 4008/4885MEN1 139/4885
US-20230113098-A1 Compositions Containing a Capsule with an Agent LIPA, CUTA, FABP4 PTGS1 3475/4885KMT2A 3786/4885MEN1 272/4885
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents MSN, LIPE, CUTA PTGS1 3800/4885KMT2A 2603/4885MEN1 84/4885
US-20210045980-A1 Grip Enhancing Compositions, and Methods and Uses Thereof ACHE, CD68, GYS1 PTGS1 2281/4885KMT2A 3211/4885MEN1 2747/4885
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents MSN, LIPE, CUTA PTGS1 3783/4885KMT2A 2641/4885MEN1 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.